Mérieux Equity Partners is one of the very best healthcare funds in Europe, combining investment excellence with the values of the Mérieux family and the expertise of Institut Mérieux and bioMérieux. They benefit from an exceptional scientific network and the group's presence in 45 countries. The fund invests in European SMEs and mid-caps that are leaders in profitable, internationalizable technical niches: pharma services, life science tools, diagnostics and medical devices (medtech).
By adding this fund to our healthcare partners, we demonstrate our strong commitment to improving wellbeing and health for all, through prevention and access to care. This is the fifth vehicle launched by the management company, reflecting significant experience and a remarkable track record, notably a special ability to source proprietary primary deals.
Copyright © 2026 AURæ
